Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 13,300 KRW
Change Today +2,300 / 20.91%
Volume 10.1M
096760 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:29 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

jw holdings corp (096760) Snapshot

Open
11,800
Previous Close
11,000
Day High
13,600
Day Low
11,650
52 Week High
07/3/15 - 13,600
52 Week Low
11/6/14 - 2,062
Market Cap
753.0B
Average Volume 10 Days
3.4M
EPS TTM
-168.00
Shares Outstanding
56.6M
EX-Date
12/29/14
P/E TM
--
Dividend
23.81
Dividend Yield
0.18%
Current Stock Chart for JW HOLDINGS CORP (096760)

Related News

No related news articles were found.

jw holdings corp (096760) Related Businessweek News

No Related Businessweek News Found

jw holdings corp (096760) Details

JW Holdings Corporation, together with its subsidiaries, supplies medicines and medical supplies worldwide. The company manufactures transfusion fluids; and medical appliances, such as digital X-rays, LED astral lamps, incubators, etc. It also exports antimicrobials, antifungal agents, anticancer agents, gastrointestinal agents, basic I.V. solutions, aminoacid solutions, triple chamber solutions, lipid emulsions, and miscellaneous products; and APIs, such as carbapenem antibiotics, cephalosporin antibiotics, and antifungals, as well as R&D products comprising linezolid, olanzapine, candesartan, olmesartan, telmisartan, and voriconazole. In addition, the company offers cell therapy products; and produces and supplies various car accessories and industrial products. JW Holdings Corporation was founded in 1945 and is based in Seoul, South Korea.

Founded in 1945

jw holdings corp (096760) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jw holdings corp (096760) Key Developments

JW Holdings Plans to Set Up an Infusion Solution Manufacturing Facility Plant in the Saudi City of Sudair

JW Holdings also plans to set up an infusion solution manufacturing facility plant in the Saudi city of Sudair, with the opening date of the plant to be determined.

JW Holdings, Chong Kun Dang, Boryung Pharm, and BC World Pharm Sign KRW 200 Billion Agreement with Sudair Pharmaceutical to Export Products to Saudi Arabia Over the Next Five Years

JW Holdings, Chong Kun Dang, Boryung Pharm, and BC World Pharm have signed agreements totaling approximately KRW 200 billion with Sudair Pharmaceutical to export products to Saudi Arabia over the next five years.

JW Holdings Corporation Recommends Some Changes to the Articles of Incorporation

JW Holdings Corporation at its AGM held on March 20, 2015, will recommend some changes to the Articles of Incorporation of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
096760:KS 13,300.00 KRW +2,300

096760 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 096760.
View Industry Companies
 

Industry Analysis

096760

Industry Average

Valuation 096760 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.2x
Price/Book 7.5x
Price/Cash Flow 3,216.0x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JW HOLDINGS CORP, please visit www.jw-holdings.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.